Next-generation sequencing for endocrine cancers: Recent advances and challenges

@article{Suresh2017NextgenerationSF,
  title={Next-generation sequencing for endocrine cancers: Recent advances and challenges},
  author={Padmanaban S. Suresh and Thejaswini Venkatesh and Rie Tsutsumi and Abhishek Shetty},
  journal={Tumor Biology},
  year={2017},
  volume={39}
}
Contemporary molecular biology research tools have enriched numerous areas of biomedical research that address challenging diseases, including endocrine cancers (pituitary, thyroid, parathyroid, adrenal, testicular, ovarian, and neuroendocrine cancers). These tools have placed several intriguing clues before the scientific community. Endocrine cancers pose a major challenge in health care and research despite considerable attempts by researchers to understand their etiology. Microarray analyses… 

Figures from this paper

EXPERT KNOWLEDGE ON HUMAN GENETIC COUNSELLING AND CHROMOSOMICS ARE NECESSARY FOR SOUND GENETIC LABORATORY DIAGNOSTICS

Being in the field of human genetic research and diagnostics since about 2 decades, during the last 10 years the author of this editorial was involved in numerous national and international education programs for young colleagues and observed, that some important aspects during education of future-CLGs definitely need more and special attention.

The prognostic value of a seven-lncRNA signature in patients with esophageal squamous cell carcinoma: a lncRNA expression analysis

The univariate and multivariate Cox regression analyses indicate that the signature is an independent factor for predicting survival of patients with ESCC and may help in treatment decision when combined with the TNM staging system.

Will long-read sequencing technologies replace short-read sequencing technologies in the next 10 years?

  • B. Adewale
  • Political Science
    African journal of laboratory medicine
  • 2020
Fred Sanger’s ‘chain-termination’ method would become the mainstay of sequencing technology for the next three decades and eventually produced a reference human genome, courtesy of the US$2.7-billion (United States dollar) Human Genome Project completed in 2003.

Finding the broken helix: The mainstreaming of genomic medicine into clinical biochemistry

  • R. Sodi
  • Medicine
    Annals of clinical biochemistry
  • 2022
‘It was a frightening and confusing year’, says sixteen-yearold Michelle, whose mother had recently been diagnosed with breast cancer. Earlier in the same year, her grandmother had succumbed to the

Transcriptome sequencing of circular RNA reveals a novel circular RNA-has_circ_0114427 in the regulation of inflammation in acute kidney injury.

The expression profile of circ RNAs in cisplatin-induced AKI is revealed and a novel insight is provided into the regulatory mechanism of circRNAs, which may become a new molecular target resource for early diagnosis and treatment strategies.

Az újgenerációs molekuláris diagnosztikai módszerek lehetőségei az endokrinológiában

Balla Bernadett1, a, b, Kocsis-Deák Barbara2, a, b, Kósa János3, a, b, Árvai Kristóf4, a, b Tobiás Bálint5, b, Takács István6, a, Lakatos Péter7, a, b 1PhD, tudományos munkatárs

References

SHOWING 1-10 OF 77 REFERENCES

Gene therapy in endocrine tumors: a comprehensive overview.

After systematically reviewing the literature, this work provides a comprehensive overview of distinct studies conducted to evaluate gene-therapy approaches in various endocrine cancers and highlights the major limitations of and the recent progress made in these therapies.

Next-generation sequencing for cancer diagnostics: a practical perspective.

There are immediate opportunities to implement NGS for clinical use and the sensitivity, speed and reduced cost per sample make it a highly attractive platform compared to other sequencing modalities.

Tumor evolution and intratumor heterogeneity of an epithelial ovarian cancer investigated using next-generation sequencing

Although a high level of intratumor heterogeneity was evident in high-grade serous ovarian cancer, the results suggest that transcoelomic metastasis arises with little accumulation of somatic mutations and copy number alterations in this patient.

Novel Mutations in Neuroendocrine Carcinoma of the Breast: Possible Therapeutic Targets

The utility of broad-based genotyping in the study of rare tumors such as neuroendocrine breast cancer is demonstrated, demonstrating the utility of comprehensive profiling of invasive ductal breast cancers for directed cancer therapy.

Frequency and clinical correlates of somatic Ying Yang 1 mutations in sporadic insulinomas.

The somatic Thr372Arg YY1 mutation is a relevant finding in female patients with sporadic insulinomas, and the prevalence of this mutation in this Caucasian population is considerably lower compared to that of a recently described Asian cohort.

Kinome sequencing reveals RET G691S polymorphism in human neuroendocrine lung cancer cell lines

The data suggest a potential association of G691S RET polymorphism with NE lung tumor, proposing the necessity of more thorough evaluation of this possibility, and the dataset of kinase mutation profiles in this report may help choosing cell line models for study of lung cancer.

Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma–like and Non–Small Cell Carcinoma–like Subsets

While exhibiting predominant similarity with lung adenocarcinoma, NSCLC-like LCNEC harbored several distinctive genomic alterations, including more frequent mutations in NOTCH family genes, implicated as key regulators of neuroendocrine differentiation.
...